Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats. 1989

T Hayashi, and Y Watanabe, and K Kumano, and R Kitayama, and T Muratani, and T Yasuda, and I Saikawa, and J Katahira, and T Kumada, and K Shimizu
Research Laboratory, Toyama Chemical Co., Ltd., Toyama, Japan.

The protective effect of piperacillin against the nephrotoxicity of cisplatin was compared with that of fosfomycin in Fischer 344 rats. Blood urea nitrogen, serum creatinine, and morphological changes were evaluated as the renal toxicological parameters. Rats receiving 2 mg of cisplatin per kg of body weight for 5 days showed significant (P less than 0.01 by multiple-comparison test) elevation of blood urea nitrogen and serum creatinine concentrations compared with rats receiving saline alone and also exhibited development of cell lesions in the pars recta of the tubules in the outer stripe of the outer medulla. However, piperacillin (250 and 1,000 mg/kg) significantly (P less than 0.01 by multiple-comparison test) reduced these toxicological parameters in comparison with results for cisplatin alone. The protective effect of piperacillin was superior to that of fosfomycin, although platinum levels in the kidney were higher with the combination of cisplatin and piperacillin than with cisplatin plus fosfomycin. Although the nephrotoxicity of cisplatin was also reduced when cisplatin was administered concomitantly with sodium chloride in mole-equivalents to 250 and 1,000 mg of piperacillin per kg, its protective effect was less than that of the corresponding piperacillin dose. These results suggest that piperacillin may have a role as a protective agent against the nephrotoxicity of cisplatin.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008297 Male Males
D010878 Piperacillin Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics. AB-Piperacillin,Cl-227193,Pipcil,Pipera-Hameln,Piperacillin Curasan,Piperacillin Fresenius,Piperacillin Hexal,Piperacillin Monosodium Salt,Piperacillin Sodium,Piperacillin-Ratiopharm,Pipercillin,Pipracil,Pipril,T-1220,T1220,AB Piperacillin,Cl 227193,Cl227193,Curasan, Piperacillin,Monosodium Salt, Piperacillin,Pipera Hameln,Piperacillin Ratiopharm,Salt, Piperacillin Monosodium,Sodium, Piperacillin,T 1220
D010984 Platinum A heavy, soft, whitish metal, resembling tin, with atomic number 78, atomic weight 195.084, symbol Pt. It is used in manufacturing equipment for laboratory and industrial use. It occurs as a black powder (platinum black) and as a spongy substance (spongy platinum) and may have been known in Pliny's time as "alutiae". Platinum Black
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D001806 Blood Urea Nitrogen The urea concentration of the blood stated in terms of nitrogen content. Serum (plasma) urea nitrogen is approximately 12% higher than blood urea nitrogen concentration because of the greater protein content of red blood cells. Increases in blood or serum urea nitrogen are referred to as azotemia and may have prerenal, renal, or postrenal causes. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984) BUN,Nitrogen, Blood Urea,Urea Nitrogen, Blood
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005578 Fosfomycin An antibiotic produced by Streptomyces fradiae. Phosphonomycin,Fosfomycin Trometamol Salt,Fosfomycin Tromethamine,Monuril,Phosphomycin,Tromethamine, Fosfomycin

Related Publications

T Hayashi, and Y Watanabe, and K Kumano, and R Kitayama, and T Muratani, and T Yasuda, and I Saikawa, and J Katahira, and T Kumada, and K Shimizu
August 2014, Human & experimental toxicology,
T Hayashi, and Y Watanabe, and K Kumano, and R Kitayama, and T Muratani, and T Yasuda, and I Saikawa, and J Katahira, and T Kumada, and K Shimizu
December 2019, Journal of advanced veterinary and animal research,
T Hayashi, and Y Watanabe, and K Kumano, and R Kitayama, and T Muratani, and T Yasuda, and I Saikawa, and J Katahira, and T Kumada, and K Shimizu
July 2008, Pakistan journal of pharmaceutical sciences,
T Hayashi, and Y Watanabe, and K Kumano, and R Kitayama, and T Muratani, and T Yasuda, and I Saikawa, and J Katahira, and T Kumada, and K Shimizu
April 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
T Hayashi, and Y Watanabe, and K Kumano, and R Kitayama, and T Muratani, and T Yasuda, and I Saikawa, and J Katahira, and T Kumada, and K Shimizu
July 2016, Canadian journal of physiology and pharmacology,
T Hayashi, and Y Watanabe, and K Kumano, and R Kitayama, and T Muratani, and T Yasuda, and I Saikawa, and J Katahira, and T Kumada, and K Shimizu
January 2013, Indian journal of pharmacology,
T Hayashi, and Y Watanabe, and K Kumano, and R Kitayama, and T Muratani, and T Yasuda, and I Saikawa, and J Katahira, and T Kumada, and K Shimizu
June 2017, BMC nephrology,
T Hayashi, and Y Watanabe, and K Kumano, and R Kitayama, and T Muratani, and T Yasuda, and I Saikawa, and J Katahira, and T Kumada, and K Shimizu
January 2016, Avicenna journal of phytomedicine,
T Hayashi, and Y Watanabe, and K Kumano, and R Kitayama, and T Muratani, and T Yasuda, and I Saikawa, and J Katahira, and T Kumada, and K Shimizu
June 2002, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP,
T Hayashi, and Y Watanabe, and K Kumano, and R Kitayama, and T Muratani, and T Yasuda, and I Saikawa, and J Katahira, and T Kumada, and K Shimizu
March 1996, Renal failure,
Copied contents to your clipboard!